Cours Kaneh Bosm Biotechnology Inc Canadian Securities Exchange
Actions
CA4841902022
Pharmacies
CA 2018 | - | CA 2019 | - | Capitalisation | 13,23 M 18,08 M 11,99 M |
---|---|---|---|---|---|
Résultat net 2018 | - 0 0 | Résultat net 2019 | -60 M -82 M -54,35 M | VE / CA 2018 * | - |
Trésorerie nette 2018 * | - 0 0 | Trésorerie nette 2019 * | - 0 0 | VE / CA 2019 * | - |
PER 2018 * |
-
| PER 2019 * |
-
| Employés | - |
Rendement 2018 * |
-
| Rendement 2019 * |
-
| Flottant | 0% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Shpilt
CEO | Chief Executive Officer | - | 15/04/19 |
Eugene Beukman
BRD | Director/Board Member | 64 | 27/04/18 |
Corporate Officer/Principal | - | 25/04/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Eugene Beukman
BRD | Director/Board Member | 64 | 27/04/18 |
Matthew Fish
BRD | Director/Board Member | - | 29/05/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+17,55% | 3,01 Md | |
+15,99% | 1,73 Md | |
+3,18% | 492 M | |
+45,54% | 186 M | |
-4,48% | 104 M | |
+0,97% | 98,08 M | |
+56,25% | 73,36 M | |
+44,94% | 53,21 M |